Iconovo to develop novel inhaled drug formulations together with University of Copenhagen

Iconovo has signed a development agreement with Copenhagen University. Iconovo’s unit-dose inhaler ICOone will be used in two PhD projects investigating novel drug formulations at Faculty of Health and Medical Sciences. ICOone is the perfect test device when developing either traditional drug formulations or novel engineered drug formulations.